SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-002566
Filing Date
2019-02-26
Accepted
2019-02-26 08:55:36
Documents
3
Period of Report
2019-02-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29745
2 ex99-1.htm EX-99.1 17585
3 ex99-1_1.jpg GRAPHIC 5537
  Complete submission text file 0001493152-19-002566.txt   56379
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
NEXIEN BIOPHARMA, INC. (Filer) CIK: 0001625288 (see all company filings)

IRS No.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-55320 | Film No.: 19631745
SIC: 2834 Pharmaceutical Preparations